$LTRN - A.I. Platform for Drug Development, RADR®, Surpasses 4.6 Bn. Datapoints, Accelerating Progress in the Devel… twitter.com/i/web/status/1…
Lantern ($LTRN) Announces Filing of Seven Patent Applications Globally on Novel DNA-Damaging Agent with Anticancer… twitter.com/i/web/status/1…
Join our team and help transform the cancer drug development process, cost and timeline! lanternpharma.com/careers/ twitter.com/therealpanna/s…
We are a biotech pharma at the intersection of Artificial Intelligence, genomics, and oncology drug development.
